Collaboration is Key to Translating the Next Generation of Cancer Research
Guest Post by Dario C. Altieri, MD The Wistar Institute
Category: Research
Guest Post by Dario C. Altieri, MD The Wistar Institute
The field of cancer immunotherapy broke new ground last week when the U.S. Food and Drug Administration (FDA) announced...
Just days before the start of multiple myeloma awareness month, which began Sunday, March 1, the U.S. Food and...
On Jan. 30, President Obama proposed a $215 million Precision Medicine Initiative, with the goal of revolutionizing medicine. This...
Yet more good news emanated from the U. S. Food and Drug Administration (FDA) last week when it announced...
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention suggests that different types of cancer fear...
Big progress was made in 2014, in the form of FDA approvals for new immunotherapies, targeted therapies, and a...
With the late-breaking and clinical trial-placeholder abstract deadlines a week away, we thought it was a good time to...